EUVIMEDEUVIMED entdecken
Crossref

Genetically enhanced mesenchymal stem cells for aging intervention

Jing-Hui LEI, Guang-Hui LIU, Si WANG

Chinese Bulletin of Life Sciences · 01.06.2026 · 38 (6) · 1152-1164

DOI: 10.3724/cbls.2026094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chinese Bulletin of Life Sciences, online erschienen am 09.07.2026. Verfasst von Jing-Hui LEI und 2 weiteren Autor:innen. Die Arbeit nennt 98 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aging is an inevitable physiological process accompanied by a gradual decline in the function of adult stem cells, which is widely recognized as a core factor of various aging-related diseases, including cardiovascular diseases, diabetes, neurodegenerative diseases and osteoporosis. Mesenchymal stem cells (MSCs), due to their advantages such as multilineage differentiation potential, immunomodulatory capacity, and low immunogenicity, are considered the most promising cell transplantation materials for delaying aging and promoting regeneration. However, after transplantation, MSCs often face extremely low survival rates and short retention times in the harsh microenvironment of the aging body, which is characterized by oxidative stress, chronic inflammation, accumulation of toxic metabolites and reduced nutrient supply, severely limiting their therapeutic efficacy in clinical applications. To address this critical bottleneck, genetic enhancement strategies have emerged as a promising solution, which employ precise gene editing technologies such as CRISPR-Cas9 to modify target genes, thereby improving the homing ability of MSCs to damaged tissues, enhancing their resistance to adverse microenvironmental stress, and promoting their paracrine secretion of beneficial cytokines. These genetically enhanced MSCs show markedly superior therapeutic efficacy relative to wild-type MSCs in the treatment of aging and related diseases. Although the long-term safety and potential risks of genetically enhanced MSCs still require further evaluation through large-sample, long-term preclinical and clinical studies, they undoubtedly represent an important breakthrough direction for the development of next-generation safe and effective anti-aging therapies.

Zitieren

APA

LEI, J., LIU, G., & WANG, S. (2026). Genetically enhanced mesenchymal stem cells for aging intervention. Chinese Bulletin of Life Sciences, 38(6), 1152-1164. https://doi.org/10.3724/cbls.2026094

Vancouver

LEI J, LIU G, WANG S. Genetically enhanced mesenchymal stem cells for aging intervention. Chinese Bulletin of Life Sciences. 2026;38(6):1152-1164. doi:10.3724/cbls.2026094

BibTeX
@article{LEI2026,
  author = {LEI, Jing-Hui and LIU, Guang-Hui and WANG, Si},
  title = {Genetically enhanced mesenchymal stem cells for aging intervention},
  journal = {Chinese Bulletin of Life Sciences},
  year = {2026},
  volume = {38},
  number = {6},
  pages = {1152--1164},
  doi = {10.3724/cbls.2026094}
}
Kostenlos starten →